Elevance Health (ELV) July option implied volatility bid into quarter results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Elevance (ELV) PT Lowered to $350 at BofA Securities
July 17, 2025 12:10 PM EDTBofA Securities analyst Kevin Fischbeck lowered the price target on Elevance (NYSE: ELV) to $350.00 (from $420.00) while maintaining a Neutral rating.
The analyst comments "Despite a Q2 in-line with company expectations, ELV cut guidance by 13%, citing higher trend in exchanges... More
